Bahrain

v. 13 – 2020/01

Market Executive Summary Use of National Data Catalogue based on GS1 standard to improve data quality and facilitate trade

The Kingdom of Bahrain’s National Health Regulatory Authority (NHRA) believes that the global standards for automatic identification provide an opportunity to make the healthcare supply chain safer as well as more efficient.

The NHRA is adopting and mandating the use of GS1 DataMatrix on the packaging of pharmaceutical products. All products must be compliant with this new regulation by 31st December 2019.

Key Dates
  • 31 July 2018: Provision of master data to National Product Catalogue, operated by GS1 UAE: GS1 UAE’s Portal (known as BrandSync) for all existing and new products supplied to the NHRA. BrandSync will be the single source of information for all product master data supplied to the NHRA. (https://brandsync.secure.force.com/BSForm/)
  • 31 Dec 2019: 2D DM with Item-level serialisation required for certain product categories
  • 01 Jan 2020: No Medicine will be imported to Bahrain unless master data has been uploaded on the BrandSync Portal.
  • 01 Sept 2021: Aggregation requirements compliance date